Compare market size and growth of key Healthcare markets

Compare market size and growth of key Healthcare markets

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Loading...

Categories

9 Oman Hyperglycemics Reports

MEA DPP-4 Inhibitors Market

Country Covered: Oman

Study Period: 2019- 2029

Major Players: Merck, Novartis, Boehringer Ingelheim, AstraZeneca, Eli Lilly and Company

Middle East And Africa Meglitinide Industry

Country Covered: Oman

Study Period: 2018 - 2029

Major Players: Novo Nordisk, Glenmark, Kissei, Novartis, Biocon

Middle East and Africa Diabetes Treatment Market

Country Covered: Oman

Study Period: 2019- 2029

Major Players: Novo Nordisk, Sanofi, Eli lilly, Wockhardt, Pfizer

Meglitinides Market

Country Covered: Oman

Study Period: 2019- 2029

Major Players: Glenmark Pharmaceuticals, Novartis, Kissei Pharmaceuticals, Biocon, Novo Nordisk A/S

SGLT2 Inhibitors Market

Country Covered: Oman

Study Period: 2019 - 2029

Major Players: Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals, Astellas

Glargine Insulin Market

Country Covered: Oman

Study Period: 2018 - 2029

Major Players: Sanofi Aventis, Novo Nordisk AS, Biocon, Eli Lilly and Company, Julphar

Basal Insulin (Long-Acting Insulin) Market

Country Covered: Oman

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Wockhardt

Sulfonylureas Industry

Country Covered: Oman

Study Period: 2019- 2029

Major Players: Sanofi Aventis, Pfizer Inc., Merck & Co., Inc., Torrent Pharma, Dr. Reddy's Laboratories

Biguanides Market

Country Covered: Oman

Study Period: 2018 - 2029

Major Players: Bristol Myers Squibb, Glenmark Pharmaceuticals, Takeda, Sanofi Aventis, Merck and Co.